Search results
Oct 20, 2023 · After serving just over a year as the U.S. Food and Drug Administration commissioner under Donald Trump, Stephen Hahn is now a CEO-partner at Cambridge-based venture firm Flagship Pioneering.
Dec 13, 2019 · The US Senate on Thursday confirmed Dr. Stephen Hahn to be the next commissioner of the US Food and Drug Administration. The Senate vote was 72 to 18.. Hahn, 59, is a well-known radiation oncology ...
Jan 21, 2021 · Radiation oncologist Stephen Hahn, MD, resigned as commissioner of the U.S. Food and Drug Administration on Wednesday, coinciding with the White House switchover in power. He first took on the post in December 2019, sworn in just ahead of the COVID-19 storm that would define the following year. Hahn faced intense pressure from former President ...
Stephen M. Hahn, M.D., is CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger Health. Steve joined Flagship in June 2021 as Chief Medical Officer of its Preemptive Health and Medicine Initiative, which is creating a new field that aims to protect, maintain, or improve people’s health before they get sick.
Jun 1, 2020 · Remarks by Commissioner Stephen Hahn, M.D., given electronically (by audio) to the Alliance for a Stronger FDA, on June 1, 2020, and recorded May 30, on video, at the HHS broadcast studio
Oct 31, 2017 · In February 2017, Stephen Hahn, M.D., was named MD Anderson's deputy president and chief operating officer. In this role, he’s responsible for day-to-day management of the institution, ensuring excellence across all business, clinical and faculty matters.
Aug 10, 2020 · In an interview, Dr. Hahn, 60, defended his record as F.D.A. chief. All of his decisions have been guided by the data, he said, and sometimes, rapidly evolving science has led to policy changes ...
